PLAC4: A Potential Drug Target and Biomarker (G191585)

Target Name: PLAC4

NCBI ID: G191585

PLAC4: A Potential Drug Target and Biomarker

Platelet-derived growth factors (PDGFs) are a family of transmembrane proteins that play a crucial role in cell-to-cell signaling and tissue repair. PDGFs are involved in various physiological processes, including wound healing, tissue regeneration, and cell survival. The PLAC4 gene is a member of the PDGF family and has been identified as a potential drug target and biomarker.

PLAC4 is a single-chain transmembrane protein that consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The protein has a calculated molecular weight of 120 kDa and a predicted localization in the cell membrane. PLAC4 is expressed in various tissues and cells, including platelets, neurons, and cancer cells.

PLAC4 functions as a cell-surface protein that is involved in cell-to-cell signaling. The protein is involved in the regulation of cell proliferation, differentiation, and survival. PLAC4 has been shown to promote the growth and survival of various cell types, including cancer cells.

PLAC4 has also been shown to play a role in the development and progression of various diseases, including cancer. For example, PLAC4 has been shown to be involved in the development of neurofibromatosis, a genetic disorder that is characterized by the formation of tumors.

PLAC4 is also a potential biomarker for several diseases, including cancer. The protein has been shown to be involved in the regulation of cell growth and survival, which could make it an attractive target for cancer therapies. For example, PLAC4 has been shown to be involved in the regulation of the growth and survival of cancer cells, which could make it an effective target for cancer therapies.

In addition to its potential as a drug target and biomarker, PLAC4 is also a potential therapeutic agent for the treatment of various diseases. The protein has been shown to have anti-inflammatory and anti-tumor effects, which could make it an attractive target for therapeutic applications.

PLAC4 is a promising drug target and biomarker due to its involvement in various physiological processes and its potential role in the development and progression of diseases. Further research is needed to fully understand the functions of PLAC4 and its potential as a drug target and biomarker.

Protein Name: Placenta Enriched 4

More Common Targets